News
05-23-2011, 09:41 PM
Exelixis, Inc. today announced the results of the phase 1 clinical trial of cabozantinib in patients with advanced solid tumors or lymphoma have been published in the current issue of the Journal of Clinical Oncology.
More... (http://www.news-medical.net/news/20110524/Journal-of-Clinical-Oncology-publishes-Exelixis-cabozantinib-phase-1-trial-results-in-lymphoma.aspx)
More... (http://www.news-medical.net/news/20110524/Journal-of-Clinical-Oncology-publishes-Exelixis-cabozantinib-phase-1-trial-results-in-lymphoma.aspx)